Corrections: The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study (The Lancet Infectious Diseases (2018) 18(5) (565–572) (S147330991830046X) (10.1016/S1473-3099(18)30046-X));The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study

The Lancet Infectious Diseases

Volumn 18, Issue 5, 2018, Pages 565-572

  Nguyen, Thuy Nhien ^a   von Seidlein, Lorenz ^b,c   Nguyen, Tuong Vy ^a   Truong, Phuc Nhi ^a   Hung, Son Do ^a   Pham, Huong Thu ^a   Nguyen, Tam Uyen ^a   Le, Thanh Dong ^d   Dao, Van Hue ^e   Mukaka, Mavuto ^b,c   Day, Nicholas PJ ^b,c   White, Nicholas J ^b,c   Dondorp, Arjen M ^b,c   Thwaites, Guy E ^a,c   Hien, Tran Tinh ^a,c  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b MAHIDOL UNIVERSITY   (Thailand)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d Institute of Malariology Parasitology and Entomology (IMPE)   (Viet Nam)

^e Center for Malariology Parasitology and Entomology Control   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROARTEMISININ; PIPERAQUINE; PRIMAQUINE; RNA 18S;

ADULT; ARTICLE; ASYMPTOMATIC INFECTION; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DENSITY; DISEASE DURATION; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; LIMIT OF DETECTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MICROSCOPY; MIXED INFECTION; OSCILLATION; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RURAL POPULATION; SINGLE DRUG DOSE; TIME TO TREATMENT; TREATMENT DURATION; VENOUS BLOOD; MIDDLE AGED; PARASITOLOGY; VIET NAM;

ADULT; COHORT STUDIES; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MIDDLE AGED; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; VIETNAM;

EID: 85041565009     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(18)30236-6     Document Type: Erratum

References (29)

1. Hamad, AA, El Hassan, IM, El Khalifa, AA, et al. Chronic Plasmodium falciparum infections in an area of low intensity malaria transmission in the Sudan. Parasitology 120 (2000), 447–456.
2. Imwong, M, Nguyen, TN, Tripura, R, et al. The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand–Myanmar border areas, Cambodia, and Vietnam. Malar J, 14, 2015, 381.
3. Okell, LC, Bousema, T, Griffin, JT, Ouedraogo, AL, Ghani, AC, Drakeley, CJ, Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun, 3, 2012, 1237.
4. Imwong, M, Stepniewska, K, Tripura, R, et al. Numerical distributions of parasite densities during asymptomatic malaria. J Infect Dis 213 (2016), 1322–1329.
5. Chen, I, Clarke, SE, Gosling, R, et al. “Asymptomatic” malaria: a chronic and debilitating infection that should be treated. PLoS Med, 13, 2016, e1001942.
6. Bousema, T, Drakeley, C, Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev 24 (2011), 377–410.
7. National Institute of Malariology Parasitology and Entomology. National Malaria Control Program report year 2015. 2016, National Institute of Malariology Parasitology and Entomology, Hanoi.
8. Lwin, KM, Phyo, AP, Tarning, J, et al. Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria. Antimicrob Agents Chemother 56 (2012), 1571–1577.
9. Tarning, J, Thana, P, Phyo, AP, et al. Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with Plasmodium vivax malaria in Thailand. CPT Pharmacometrics Syst Pharmacol, 3, 2014, e132.
10. White, NJ, Qiao, LG, Qi, G, Luzzatto, L, Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. Malar J, 11, 2012, 418.
11. Imwong, M, Hanchana, S, Malleret, B, et al. High throughput ultra-sensitive molecular techniques to quantify low density malaria parasitaemias. J Clin Microbiol 9 (2014), 3003–3009.
12. Kamau, E, Tolbert, LS, Kortepeter, L, et al. Development of a highly sensitive genus-specific quantitative reverse transcriptase real-time PCR assay for detection and quantitation of plasmodium by amplifying RNA and DNA of the 18S rRNA genes. J Clin Microbiol 49 (2011), 2946–2953.
13. Cuzick, J, A Wilcoxon-type test for trend. Stat Med 4 (1985), 87–90.
14. Collins, WE, Jeffery, GM, A retrospective examination of the patterns of recrudescence in patients infected with Plasmodium falciparum. Am J Trop Med Hyg 61:suppl 1 (1999), 44–48.
15. Collins, WE, Jeffery, GM, A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum in patients previously infected with heterologous species of Plasmodium: effect on development of parasitologic and clinical immunity. Am J Trop Med Hyg 61:suppl 1 (1999), 36–43.
16. Eyles, DE, Young, MD, The duration of untreated or inadequately treated Plasmodium falciparum infections in the human host. J Natl Malar Soc 10 (1951), 327–336.
17. McKenzie, FE, Jeffery, GM, Collins, WE, Plasmodium vivax blood-stage dynamics. J Parasitol 88 (2002), 521–535.
18. Ashley, EA, White, NJ, The duration of Plasmodium falciparum infections. Malar J, 13, 2014, 500.
19. Babiker, HA, Abdel-Muhsin, AM, Ranford-Cartwright, LC, Satti, G, Walliker, D, Characteristics of Plasmodium falciparum parasites that survive the lengthy dry season in eastern Sudan where malaria transmission is markedly seasonal. Am J Trop Med Hyg 59 (1998), 582–590.
20. Sama, W, Dietz, K, Smith, T, Distribution of survival times of deliberate Plasmodium falciparum infections in tertiary syphilis patients. Trans R Soc Trop Med Hyg 100 (2006), 811–816.
21. Bruce, MC, Galinski, MR, Barnwell, JW, et al. Genetic diversity and dynamics of Plasmodium falciparum and P vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea. Parasitology 121 (2000), 257–272.
22. Baliraine, FN, Afrane, YA, Amenya, DA, et al. A cohort study of Plasmodium falciparum infection dynamics in Western Kenya Highlands. BMC Infect Dis, 10, 2010, 283.
23. Franks, S, Koram, KA, Wagner, GE, et al. Frequent and persistent, asymptomatic Plasmodium falciparum infections in African infants, characterized by multilocus genotyping. J Infect Dis 183 (2001), 796–804.
24. Felger, I, Maire, M, Bretscher, MT, et al. The dynamics of natural Plasmodium falciparum infections. PLoS One, 7, 2012, e45542.
25. Farnert, A, Snounou, G, Rooth, I, Bjorkman, A, Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. Am J Trop Med Hyg 56 (1997), 538–547.
26. Tripura, R, Peto, TJ, Chalk, J, et al. Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies. Malar J, 15, 2016, 181.
27. Group, AC, Phok, S, Lek, D, Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies. Malar J, 16, 2017, 171.
28. Miotto, O, Amato, R, Ashley, EA, et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet 47 (2015), 226–234.
29. Scherf, A, Lopez-Rubio, JJ, Riviere, L, Antigenic variation in Plasmodium falciparum. Annu Rev Microbiol 62 (2008), 445–470.